1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Pathology Analysis & Statistics

Pathology Analysis & Statistics

1-30 of about 1900 reports

Tinea Pedis (Athlete Foot) (Infectious Disease) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 37 pages

Tinea Pedis (Athlete Foot) (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Tinea Pedis (Athlete Foot) – Drugs In Development, ...

  • World
  • United States
  • Antifungal
  • Infectious Disease
  • Industry analysis

Meningitis (Infectious Disease) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 89 pages

Meningitis (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Meningitis – Drugs In Development, 2021, provides an overview of ...

  • World
  • India
  • Meningococcal
  • Drug Development
  • Industry analysis
  • HIV AIDS Prevalence
  • HIV AIDS Mortality Rate

Toxoplasmosis (Infectious Disease) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 48 pages

Toxoplasmosis (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Toxoplasmosis – Drugs In Development, 2021, provides an overview ...

  • World
  • Infectious Disease
  • Drug Development
  • Industry analysis
  • Health Provider Density

Middle East Respiratory Syndrome (MERS) (Infectious Disease) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 179 pages

Middle East Respiratory Syndrome (MERS) (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Middle East Respiratory Syndrome (MERS) ...

  • Middle East
  • Infectious Disease
  • Drug Development
  • Industry analysis
  • Mortality Rate
  • Hospital Discharge

Dengue Fever (Infectious Disease) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 203 pages

Dengue Fever (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Dengue Fever – Drugs In Development, 2021, provides an overview ...

  • World
  • Asia
  • Infectious Disease
  • Drug Development
  • Industry analysis
  • Drug Approval
  • Pharmaceutical Registrations

Zika Virus Infections (Infectious Disease) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 258 pages

Zika Virus Infections (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Zika Virus Infections – Drugs In Development, 2021, provides ...

  • World
  • United States
  • Infectious Disease
  • Drug Development
  • Industry analysis
  • Drug Approval
  • Pharmaceutical Registrations

Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 114 pages

Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H7N9 Subtype Infections ...

  • World
  • China
  • Influenza
  • Drug Development
  • Industry analysis
  • Drug Approval
  • Infectious Disease Mortality

Poliomyelitis (Infectious Disease) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 104 pages

Poliomyelitis (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Poliomyelitis – Drugs In Development, 2021, provides an overview ...

  • World
  • China
  • Infectious Disease
  • Drug Development
  • Industry analysis
  • Vaccination Coverage
  • Child Immunisation Coverage

Eastern Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 44 pages

Eastern Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Eastern Equine Encephalitis – Drugs In Development, ...

  • World
  • Venezuela
  • Encephalitis
  • Drug Development
  • Industry analysis
  • Cause-Specific Mortality Rate
  • Mortality Rate

Western Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 33 pages

Western Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Western Equine Encephalitis – Drugs In Development, ...

  • World
  • Northern Europe
  • Encephalitis
  • Drug Development
  • Industry analysis
  • Mortality Rate

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 88 pages

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Fibrodysplasia ...

  • World
  • South Africa
  • Drug Development
  • Musculoskeletal Disorder
  • Industry analysis
  • Pharmaceutical Registrations
  • Smoking Prevalence

Hyperphosphatemia In Chronic Kidney Disease (Nutritional Disorders) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 75 pages

Hyperphosphatemia In Chronic Kidney Disease (Nutritional Disorders) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosphatemia In Chronic Kidney ...

  • World
  • China
  • Chronic Disease
  • Drug Development
  • Industry analysis
  • Patients Undergoing Dialysis
  • Drug Approval

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) - Drugs in Development, 2021

  • $ 2500
  • December 2021
  • 4011 pages

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia ...

  • World
  • Leukemia
  • Industry analysis

Multiple Myeloma (Kahler Disease) (Oncology) - Drugs in Development, 2021

  • $ 2500
  • December 2021
  • 2980 pages

Multiple Myeloma (Kahler Disease) (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) – Drugs In Development, ...

  • World
  • Cancer
  • Industry analysis

Medulloblastoma (Oncology) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 556 pages

Medulloblastoma (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Medulloblastoma – Drugs In Development, 2021, provides an overview of ...

  • World
  • Cancer
  • Therapy
  • Industry analysis

Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021

  • $ 2500
  • December 2021
  • 3486 pages

Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Drugs In Development, 2021, ...

  • World
  • Brain Cancer
  • Therapy
  • Industry analysis

Recurrent Malignant Glioma (Oncology) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 56 pages

Recurrent Malignant Glioma (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Recurrent Malignant Glioma – Drugs In Development, 2021, provides ...

  • World
  • Hebei
  • Cancer
  • Drug Development
  • Industry analysis
  • Drug Approval
  • Life Expectancy

Bile Duct Cancer (Cholangiocarcinoma) (Oncology) - Drugs in Development, 2021

  • $ 2500
  • December 2021
  • 2359 pages

Bile Duct Cancer (Cholangiocarcinoma) (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocarcinoma) – Drugs In ...

  • World
  • Cancer
  • Industry analysis

Merkel Cell Carcinoma (Oncology) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 1010 pages

Merkel Cell Carcinoma (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Merkel Cell Carcinoma – Drugs In Development, 2021, provides an ...

  • World
  • Cancer
  • Industry analysis

Age Related Macular Degeneration (Ophthalmology) - Drugs in Development, 2021

  • $ 2500
  • December 2021
  • 1196 pages

Age Related Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Age Related Macular Degeneration – Drugs In Development, ...

  • World
  • Ophthalmology
  • Eye Disease
  • Industry analysis

Ovarian Cancer (Oncology) - Drugs in Development, 2021

  • $ 2500
  • December 2021
  • 5066 pages

Ovarian Cancer (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Drugs In Development, 2021, provides an overview of the ...

  • World
  • Ovarian Cancer
  • Industry analysis

Kidney Cancer (Renal Cell Cancer) (Oncology) - Drugs in Development, 2021

  • $ 2500
  • December 2021
  • 4110 pages

Kidney Cancer (Renal Cell Cancer) (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) – Drugs In Development, ...

  • World
  • Renal Cancer
  • Industry analysis

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Drugs In Development, 2021

  • $ 3500
  • December 2021
  • 62 pages

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Drugs In Development, 2021 Summary Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC ...

  • World
  • Pharmaceutical
  • Therapy
  • Industry analysis
  • Mortality Rate
  • Pharmaceutical Exports

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drugs In Development, 2021

  • $ 3500
  • December 2021
  • 90 pages

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drugs In Development, 2021 Summary Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma ...

  • World
  • Pharmaceutical
  • Cancer
  • Industry analysis

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Drugs In Development, 2021

  • $ 3500
  • December 2021
  • 93 pages

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Drugs In Development, 2021 Summary Survival Motor Neuron Protein (Component of Gems 1 or Gemin 1 or SMN1 or SMN2) pipeline ...

  • World
  • Neurological Disorder
  • Industry analysis
  • Medical Technology Density
  • Cause-Specific Mortality Rate

Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) - Drugs In Development, 2021

  • $ 3500
  • December 2021
  • 58 pages

Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) - Drugs In Development, 2021 Summary According to the recently published report ’Leptin Receptor – Drugs In Development, 2021’; Leptin Recepto ...

  • World
  • Pharmaceutical
  • Breast Cancer
  • Industry analysis
  • Pharmaceutical Registrations
  • Mortality Rate

Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Drugs In Development, 2021

  • $ 3500
  • December 2021
  • 77 pages

Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Drugs In Development, 2021 Summary Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) pipeline Target constitutes close to 12 molecules. ...

  • World
  • United States
  • Autoimmune Disease
  • Pharmaceutical
  • Industry analysis
  • Drug Approval
  • Pharmaceutical Exports

Prostate Cancer (Oncology) - Drugs in Development, 2021

  • $ 2500
  • November 2021
  • 4131 pages

Prostate Cancer (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Drugs In Development, 2021, provides an overview of the ...

  • World
  • Prostate Cancer
  • Industry analysis

Small-Cell Lung Cancer (Oncology) - Drugs in Development, 2021

  • $ 2500
  • November 2021
  • 2115 pages

Small-Cell Lung Cancer (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer - Drugs In Development, 2021, provides an ...

  • World
  • Lung Cancer
  • Industry analysis

Gastrointestinal Stromal Tumor (GIST) (Oncology) - Drugs in Development, 2021

  • $ 2000
  • November 2021
  • 866 pages

Gastrointestinal Stromal Tumor (GIST) (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Gastrointestinal Stromal Tumor - Drugs In Development, ...

  • World
  • Cancer
  • Industry analysis
About 59000 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Respiratory Disease Sales Statistics in Nigeria

  • January 2022
  • 10 pages
  • Nigeria
  • West Africa
  • Respiratory Disease
  • Industry analysis
  • Infectious Disease Mortality
  • Maternal Mortality Rate

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on